Business Context and Reporting Period
Company: Phibro Animal Health Corporation (PAHC)
Filing Type: Form 8-K (Current Report)
Date of Report: February 5, 2025
Reporting Period: Fiscal quarter ended December 31, 2024
This filing serves as a notification that the company issued a press release on February 5, 2025, detailing operating results for the quarter ended December 31, 2024, and providing financial guidance for the fiscal year ending June 30, 2025.
Key Financial Metrics
The provided text is a cover sheet and does not contain specific numerical data. The following metrics are referenced as being contained in the attached press release (Exhibit 99.1) but are not listed in this document:
- Revenue: Not provided in text.
- Profit: Not provided in text.
- Cash Flow: Not provided in text.
- Margins: Not provided in text.
- Debt and Liquidity: Not provided in text.
Material Changes
The filing text does not provide specific details regarding material changes versus the prior comparable period. It only confirms that operating results for the quarter ended December 31, 2024, were announced.
Guidance, Outlook, and Risks
- Guidance: The company issued financial guidance for the fiscal year ending June 30, 2025, as part of the February 5, 2025 press release.
- Management Commentary: Specific commentary is contained in the attached press release (Exhibit 99.1) and is not detailed in this 8-K summary text.
- Risks and Contingencies: No specific risks or contingencies are described in this filing text.
- Unusual Items: None identified in the provided text.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release dated February 5, 2025) for actual revenue, earnings, and cash flow figures for the quarter ended December 31, 2024.
- Verify the specific numerical targets included in the full-year 2025 guidance referenced in the press release.
- Confirm any material changes in operating performance compared to the prior year quarter as detailed in the exhibit.
- Check for any forward-looking statements or risk factors disclosed in the press release that may impact future performance.